Table of Content

1 PD-1 and PD-L1 Inhibitors Market Overview
1.1 PD-1 and PD-L1 Inhibitors Product Scope
1.2 PD-1 and PD-L1 Inhibitors Segment by Type
1.2.1 Global PD-1 and PD-L1 Inhibitors Sales by Type (2016 & 2021 & 2027)
1.2.2 PD-1 Inhibitors
1.2.3 PD-L1 Inhibitors
1.3 PD-1 and PD-L1 Inhibitors Segment by Application
1.3.1 Global PD-1 and PD-L1 Inhibitors Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Solid Tumors
1.3.3 Blood-related Tumors
1.4 PD-1 and PD-L1 Inhibitors Market Estimates and Forecasts (2016-2027)
1.4.1 Global PD-1 and PD-L1 Inhibitors Market Size in Value Growth Rate (2016-2027)
1.4.2 Global PD-1 and PD-L1 Inhibitors Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global PD-1 and PD-L1 Inhibitors Price Trends (2016-2027)

2 PD-1 and PD-L1 Inhibitors Estimates and Forecasts by Region
2.1 Global PD-1 and PD-L1 Inhibitors Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global PD-1 and PD-L1 Inhibitors Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2016-2021)
2.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2016-2021)
2.3 Global PD-1 and PD-L1 Inhibitors Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global PD-1 and PD-L1 Inhibitors Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America PD-1 and PD-L1 Inhibitors Estimates and Projections (2016-2027)
2.4.2 Europe PD-1 and PD-L1 Inhibitors Estimates and Projections (2016-2027)
2.4.3 China PD-1 and PD-L1 Inhibitors Estimates and Projections (2016-2027)
2.4.4 Japan PD-1 and PD-L1 Inhibitors Estimates and Projections (2016-2027)
2.4.5 Southeast Asia PD-1 and PD-L1 Inhibitors Estimates and Projections (2016-2027)
2.4.6 India PD-1 and PD-L1 Inhibitors Estimates and Projections (2016-2027)
3 Global PD-1 and PD-L1 Inhibitors Competition Landscape by Players
3.1 Global Top PD-1 and PD-L1 Inhibitors Players by Sales (2016-2021)
3.2 Global Top PD-1 and PD-L1 Inhibitors Players by Revenue (2016-2021)
3.3 Global PD-1 and PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Inhibitors as of 2020)
3.4 Global PD-1 and PD-L1 Inhibitors Average Price by Company (2016-2021)
3.5 Manufacturers PD-1 and PD-L1 Inhibitors Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global PD-1 and PD-L1 Inhibitors Market Size by Type
4.1 Global PD-1 and PD-L1 Inhibitors Historic Market Review by Type (2016-2021)
4.1.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)
4.1.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2016-2021)
4.1.3 Global PD-1 and PD-L1 Inhibitors Price by Type (2016-2021)
4.2 Global PD-1 and PD-L1 Inhibitors Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global PD-1 and PD-L1 Inhibitors Sales Forecast by Type (2022-2027)
4.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Type (2022-2027)
4.2.3 Global PD-1 and PD-L1 Inhibitors Price Forecast by Type (2022-2027)
5 Global PD-1 and PD-L1 Inhibitors Market Size by Application
5.1 Global PD-1 and PD-L1 Inhibitors Historic Market Review by Application (2016-2021)
5.1.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)
5.1.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application (2016-2021)
5.1.3 Global PD-1 and PD-L1 Inhibitors Price by Application (2016-2021)
5.2 Global PD-1 and PD-L1 Inhibitors Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global PD-1 and PD-L1 Inhibitors Sales Forecast by Application (2022-2027)
5.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Application (2022-2027)
5.2.3 Global PD-1 and PD-L1 Inhibitors Price Forecast by Application (2022-2027)

6 North America PD-1 and PD-L1 Inhibitors Market Facts & Figures
6.1 North America PD-1 and PD-L1 Inhibitors Sales by Company
6.1.1 North America PD-1 and PD-L1 Inhibitors Sales by Company (2016-2021)
6.1.2 North America PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021)
6.2 North America PD-1 and PD-L1 Inhibitors Sales Breakdown by Type
6.2.1 North America PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2016-2021)
6.2.2 North America PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2022-2027)
6.3 North America PD-1 and PD-L1 Inhibitors Sales Breakdown by Application
6.3.1 North America PD-1 and PD-L1 Inhibitors Sales Breakdown by Application (2016-2021)
6.3.2 North America PD-1 and PD-L1 Inhibitors Sales Breakdown by Application (2022-2027)

7 Europe PD-1 and PD-L1 Inhibitors Market Facts & Figures
7.1 Europe PD-1 and PD-L1 Inhibitors Sales by Company
7.1.1 Europe PD-1 and PD-L1 Inhibitors Sales by Company (2016-2021)
7.1.2 Europe PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021)
7.2 Europe PD-1 and PD-L1 Inhibitors Sales Breakdown by Type
7.2.1 Europe PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2016-2021)
7.2.2 Europe PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2022-2027)
7.3 Europe PD-1 and PD-L1 Inhibitors Sales Breakdown by Application
7.3.1 Europe 131 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 131 Sales Breakdown by Application (2022-2027)

8 China PD-1 and PD-L1 Inhibitors Market Facts & Figures
8.1 China PD-1 and PD-L1 Inhibitors Sales by Company
8.1.1 China PD-1 and PD-L1 Inhibitors Sales by Company (2016-2021)
8.1.2 China PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021)
8.2 China PD-1 and PD-L1 Inhibitors Sales Breakdown by Type
8.2.1 China PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2016-2021)
8.2.2 China PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2022-2027)
8.3 China PD-1 and PD-L1 Inhibitors Sales Breakdown by Application
8.3.1 China 242 Sales Breakdown by Application (2016-2021)
8.3.2 China 242 Sales Breakdown by Application (2022-2027)

9 Japan PD-1 and PD-L1 Inhibitors Market Facts & Figures
9.1 Japan PD-1 and PD-L1 Inhibitors Sales by Company
9.1.1 Japan PD-1 and PD-L1 Inhibitors Sales by Company (2016-2021)
9.1.2 Japan PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021)
9.2 Japan PD-1 and PD-L1 Inhibitors Sales Breakdown by Type
9.2.1 Japan PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2016-2021)
9.2.2 Japan PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2022-2027)
9.3 Japan PD-1 and PD-L1 Inhibitors Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia PD-1 and PD-L1 Inhibitors Market Facts & Figures
10.1 Southeast Asia PD-1 and PD-L1 Inhibitors Sales by Company
10.1.1 Southeast Asia PD-1 and PD-L1 Inhibitors Sales by Company (2016-2021)
10.1.2 Southeast Asia PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021)
10.2 Southeast Asia PD-1 and PD-L1 Inhibitors Sales Breakdown by Type
10.2.1 Southeast Asia PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia PD-1 and PD-L1 Inhibitors Sales Breakdown by Application
10.3.1 Southeast Asia L Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia L Sales Breakdown by Application (2022-2027)

11 India PD-1 and PD-L1 Inhibitors Market Facts & Figures
11.1 India PD-1 and PD-L1 Inhibitors Sales by Company
11.1.1 India PD-1 and PD-L1 Inhibitors Sales by Company (2016-2021)
11.1.2 India PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021)
11.2 India PD-1 and PD-L1 Inhibitors Sales Breakdown by Type
11.2.1 India PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2016-2021)
11.2.2 India PD-1 and PD-L1 Inhibitors Sales Breakdown by Type (2022-2027)
11.3 India PD-1 and PD-L1 Inhibitors Sales Breakdown by Application
11.3.1 India PD-1 and PD-L1 Inhibitors Sales Breakdown by Application (2016-2021)
11.3.2 India PD-1 and PD-L1 Inhibitors Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in PD-1 and PD-L1 Inhibitors Business
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Business Overview
12.1.3 Merck PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck PD-1 and PD-L1 Inhibitors Products Offered
12.1.5 Merck Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Corporation Information
12.2.2 Bristol-Myers Squibb Business Overview
12.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Products Offered
12.2.5 Bristol-Myers Squibb Recent Development
12.3 Roche
12.3.1 Roche Corporation Information
12.3.2 Roche Business Overview
12.3.3 Roche PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Roche PD-1 and PD-L1 Inhibitors Products Offered
12.3.5 Roche Recent Development
12.4 AstraZeneca
12.4.1 AstraZeneca Corporation Information
12.4.2 AstraZeneca Business Overview
12.4.3 AstraZeneca PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.4.4 AstraZeneca PD-1 and PD-L1 Inhibitors Products Offered
12.4.5 AstraZeneca Recent Development
12.5 Ono Pharmaceutical
12.5.1 Ono Pharmaceutical Corporation Information
12.5.2 Ono Pharmaceutical Business Overview
12.5.3 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Products Offered
12.5.5 Ono Pharmaceutical Recent Development
12.6 Regeneron
12.6.1 Regeneron Corporation Information
12.6.2 Regeneron Business Overview
12.6.3 Regeneron PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Regeneron PD-1 and PD-L1 Inhibitors Products Offered
12.6.5 Regeneron Recent Development
12.7 Innovent
12.7.1 Innovent Corporation Information
12.7.2 Innovent Business Overview
12.7.3 Innovent PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Innovent PD-1 and PD-L1 Inhibitors Products Offered
12.7.5 Innovent Recent Development
12.8 Hengrui Medicine
12.8.1 Hengrui Medicine Corporation Information
12.8.2 Hengrui Medicine Business Overview
12.8.3 Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Hengrui Medicine PD-1 and PD-L1 Inhibitors Products Offered
12.8.5 Hengrui Medicine Recent Development
12.9 Junshi Biosciences
12.9.1 Junshi Biosciences Corporation Information
12.9.2 Junshi Biosciences Business Overview
12.9.3 Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Junshi Biosciences PD-1 and PD-L1 Inhibitors Products Offered
12.9.5 Junshi Biosciences Recent Development
12.10 Merck KGaA
12.10.1 Merck KGaA Corporation Information
12.10.2 Merck KGaA Business Overview
12.10.3 Merck KGaA PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Merck KGaA PD-1 and PD-L1 Inhibitors Products Offered
12.10.5 Merck KGaA Recent Development

13 PD-1 and PD-L1 Inhibitors Manufacturing Cost Analysis
13.1 PD-1 and PD-L1 Inhibitors Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
13.4 PD-1 and PD-L1 Inhibitors Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 PD-1 and PD-L1 Inhibitors Distributors List
14.3 PD-1 and PD-L1 Inhibitors Customers

15 Market Dynamics
15.1 PD-1 and PD-L1 Inhibitors Market Trends
15.2 PD-1 and PD-L1 Inhibitors Drivers
15.3 PD-1 and PD-L1 Inhibitors Market Challenges
15.4 PD-1 and PD-L1 Inhibitors Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global PD-1 and PD-L1 Inhibitors Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global PD-1 and PD-L1 Inhibitors Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global PD-1 and PD-L1 Inhibitors Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global PD-1 and PD-L1 Inhibitors Sales (L) by Region (2016-2021)
Table 5. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2016-2021)
Table 6. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global PD-1 and PD-L1 Inhibitors Revenue Share by Region (2016-2021)
Table 8. Global PD-1 and PD-L1 Inhibitors Sales (L) Forecast by Region (2022-2027)
Table 9. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Region (2022-2027)
Table 10. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global PD-1 and PD-L1 Inhibitors Revenue Share Forecast by Region (2022-2027)
Table 12. Global PD-1 and PD-L1 Inhibitors Sales (L) of Key Companies (2016-2021)
Table 13. Global PD-1 and PD-L1 Inhibitors Sales Share by Company (2016-2021)
Table 14. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) by Company (2016-2021)
Table 15. Global PD-1 and PD-L1 Inhibitors Revenue Share by Company (2016-2021)
Table 16. Global PD-1 and PD-L1 Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-1 and PD-L1 Inhibitors as of 2020)
Table 17. Global PD-1 and PD-L1 Inhibitors Average Price (USD/ml) of Key Company (2016-2021)
Table 18. Manufacturers PD-1 and PD-L1 Inhibitors Manufacturing Sites and Area Served
Table 19. Manufacturers PD-1 and PD-L1 Inhibitors Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global PD-1 and PD-L1 Inhibitors Sales (L) by Type (2016-2021)
Table 22. Global PD-1 and PD-L1 Inhibitors Sales Share by Type (2016-2021)
Table 23. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global PD-1 and PD-L1 Inhibitors Price (USD/ml) by Type (2016-2021)
Table 25. Global PD-1 and PD-L1 Inhibitors Sales Share by Type (2022-2027)
Table 26. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global PD-1 and PD-L1 Inhibitors Revenue Share by Type (2022-2027)
Table 28. Global PD-1 and PD-L1 Inhibitors Price (USD/ml) by Type (2022-2027)
Table 29. Global PD-1 and PD-L1 Inhibitors Sales (L) by Application (2016-2021)
Table 30. Global PD-1 and PD-L1 Inhibitors Sales Share by Application (2016-2021)
Table 31. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global PD-1 and PD-L1 Inhibitors Price (USD/ml) by Application (2016-2021)
Table 33. Global PD-1 and PD-L1 Inhibitors Sales (L) by Application (2022-2027)
Table 34. Global PD-1 and PD-L1 Inhibitors Sales Share by Application (2022-2027)
Table 35. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global PD-1 and PD-L1 Inhibitors Revenue Share by Application (2022-2027)
Table 37. Global PD-1 and PD-L1 Inhibitors Price (USD/ml) by Application (2022-2027)
Table 38. North America PD-1 and PD-L1 Inhibitors Sales (L) by Company (2016-2021)
Table 39. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2016-2021)
Table 40. North America PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2016-2021)
Table 42. North America PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021) & (L)
Table 43. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)
Table 44. North America PD-1 and PD-L1 Inhibitors Sales by Type (2022-2027) & (L)
Table 45. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2022-2027)
Table 46. North America PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021) & (L)
Table 47. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)
Table 48. North America PD-1 and PD-L1 Inhibitors Sales by Application (2022-2027) & (L)
Table 49. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2022-2027)
Table 50. Europe PD-1 and PD-L1 Inhibitors Sales (L) by Company (2016-2021)
Table 51. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2016-2021)
Table 52. Europe PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2016-2021)
Table 54. Europe PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021) & (L)
Table 55. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)
Table 56. Europe PD-1 and PD-L1 Inhibitors Sales by Type (2022-2027) & (L)
Table 57. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2022-2027)
Table 58. Europe PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021) & (L)
Table 59. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)
Table 60. Europe PD-1 and PD-L1 Inhibitors Sales by Application (2022-2027) & (L)
Table 61. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2022-2027)
Table 62. China PD-1 and PD-L1 Inhibitors Sales (L) by Company (2016-2021)
Table 63. China PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2016-2021)
Table 64. China PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 65. China PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2016-2021)
Table 66. China PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021) & (L)
Table 67. China PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)
Table 68. China PD-1 and PD-L1 Inhibitors Sales by Type (2022-2027) & (L)
Table 69. China PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2022-2027)
Table 70. China PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021) & (L)
Table 71. China PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)
Table 72. China PD-1 and PD-L1 Inhibitors Sales by Application (2022-2027) & (L)
Table 73. China PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2022-2027)
Table 74. Japan PD-1 and PD-L1 Inhibitors Sales (L) by Company (2016-2021)
Table 75. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2016-2021)
Table 76. Japan PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2016-2021)
Table 78. Japan PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021) & (L)
Table 79. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)
Table 80. Japan PD-1 and PD-L1 Inhibitors Sales by Type (2022-2027) & (L)
Table 81. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2022-2027)
Table 82. Japan PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021) & (L)
Table 83. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)
Table 84. Japan PD-1 and PD-L1 Inhibitors Sales by Application (2022-2027) & (L)
Table 85. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia PD-1 and PD-L1 Inhibitors Sales (L) by Company (2016-2021)
Table 87. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021) & (L)
Table 91. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia PD-1 and PD-L1 Inhibitors Sales by Type (2022-2027) & (L)
Table 93. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021) & (L)
Table 95. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia PD-1 and PD-L1 Inhibitors Sales by Application (2022-2027) & (L)
Table 97. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2022-2027)
Table 98. India PD-1 and PD-L1 Inhibitors Sales (L) by Company (2016-2021)
Table 99. India PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2016-2021)
Table 100. India PD-1 and PD-L1 Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 101. India PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2016-2021)
Table 102. India PD-1 and PD-L1 Inhibitors Sales by Type (2016-2021) & (L)
Table 103. India PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2016-2021)
Table 104. India PD-1 and PD-L1 Inhibitors Sales by Type (2022-2027) & (L)
Table 105. India PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2022-2027)
Table 106. India PD-1 and PD-L1 Inhibitors Sales by Application (2016-2021) & (L)
Table 107. India PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2016-2021)
Table 108. India PD-1 and PD-L1 Inhibitors Sales by Application (2022-2027) & (L)
Table 109. India PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2022-2027)
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2016-2021)
Table 113. Merck PD-1 and PD-L1 Inhibitors Product
Table 114. Merck Recent Development
Table 115. Bristol-Myers Squibb Corporation Information
Table 116. Bristol-Myers Squibb Description and Business Overview
Table 117. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2016-2021)
Table 118. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product
Table 119. Bristol-Myers Squibb Recent Development
Table 120. Roche Corporation Information
Table 121. Roche Description and Business Overview
Table 122. Roche PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2016-2021)
Table 123. Roche PD-1 and PD-L1 Inhibitors Product
Table 124. Roche Recent Development
Table 125. AstraZeneca Corporation Information
Table 126. AstraZeneca Description and Business Overview
Table 127. AstraZeneca PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2016-2021)
Table 128. AstraZeneca PD-1 and PD-L1 Inhibitors Product
Table 129. AstraZeneca Recent Development
Table 130. Ono Pharmaceutical Corporation Information
Table 131. Ono Pharmaceutical Description and Business Overview
Table 132. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2016-2021)
Table 133. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product
Table 134. Ono Pharmaceutical Recent Development
Table 135. Regeneron Corporation Information
Table 136. Regeneron Description and Business Overview
Table 137. Regeneron PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2016-2021)
Table 138. Regeneron PD-1 and PD-L1 Inhibitors Product
Table 139. Regeneron Recent Development
Table 140. Innovent Corporation Information
Table 141. Innovent Description and Business Overview
Table 142. Innovent PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2016-2021)
Table 143. Innovent PD-1 and PD-L1 Inhibitors Product
Table 144. Innovent Recent Development
Table 145. Hengrui Medicine Corporation Information
Table 146. Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2016-2021)
Table 147. Hengrui Medicine Description and Business Overview
Table 148. Hengrui Medicine PD-1 and PD-L1 Inhibitors Product
Table 149. Hengrui Medicine Recent Development
Table 150. Junshi Biosciences Corporation Information
Table 151. Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2016-2021)
Table 152. Junshi Biosciences Description and Business Overview
Table 153. Junshi Biosciences PD-1 and PD-L1 Inhibitors Product
Table 154. Junshi Biosciences Recent Development
Table 155. Merck KGaA Corporation Information
Table 156. Merck KGaA Description and Business Overview
Table 157. Merck KGaA PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2016-2021)
Table 158. Merck KGaA PD-1 and PD-L1 Inhibitors Product
Table 159. Merck KGaA Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. PD-1 and PD-L1 Inhibitors Distributors List
Table 163. PD-1 and PD-L1 Inhibitors Customers List
Table 164. PD-1 and PD-L1 Inhibitors Market Trends
Table 165. PD-1 and PD-L1 Inhibitors Market Drivers
Table 166. PD-1 and PD-L1 Inhibitors Market Challenges
Table 167. PD-1 and PD-L1 Inhibitors Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. PD-1 and PD-L1 Inhibitors Product Picture
Figure 2. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2021 & 2027
Figure 6. Solid Tumors Examples
Figure 7. Blood-related Tumors Examples
Figure 8. Global PD-1 and PD-L1 Inhibitors Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global PD-1 and PD-L1 Inhibitors Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global PD-1 and PD-L1 Inhibitors Sales (L) Growth Rate (2016-2027)
Figure 11. Global PD-1 and PD-L1 Inhibitors Price Trends Growth Rate (2016-2027) (USD/ml)
Figure 12. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America PD-1 and PD-L1 Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America PD-1 and PD-L1 Inhibitors Sales (L) Growth Rate (2016-2027)
Figure 16. Europe PD-1 and PD-L1 Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe PD-1 and PD-L1 Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China PD-1 and PD-L1 Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China PD-1 and PD-L1 Inhibitors Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan PD-1 and PD-L1 Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan PD-1 and PD-L1 Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia PD-1 and PD-L1 Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia PD-1 and PD-L1 Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India PD-1 and PD-L1 Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India PD-1 and PD-L1 Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest PD-1 and PD-L1 Inhibitors Players Market Share by Revenue in PD-1 and PD-L1 Inhibitors: 2016 & 2020
Figure 27. PD-1 and PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global PD-1 and PD-L1 Inhibitors Revenue Share by Type (2016-2021)
Figure 29. Global PD-1 and PD-L1 Inhibitors Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global PD-1 and PD-L1 Inhibitors Revenue Share by Application (2016-2021)
Figure 31. Global PD-1 and PD-L1 Inhibitors Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020
Figure 33. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2020
Figure 34. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020
Figure 35. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2020
Figure 36. China PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020
Figure 37. China PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2020
Figure 38. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020
Figure 39. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2020
Figure 40. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020
Figure 41. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2020
Figure 42. India PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020
Figure 43. India PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of PD-1 and PD-L1 Inhibitors
Figure 46. Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
Figure 47. PD-1 and PD-L1 Inhibitors Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed